Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - atorvastatin calcium -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - gabapentin -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - latanoprost -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - paracetamol -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - quinapril hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sertraline hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer consumer healthcare div. of pfizer new zealand ltd - glucose monohydrate; sodium chloride - tablet - 190mg/450mg - active: glucose monohydrate sodium chloride

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - celecoxib 400mg;   - capsule - 400 mg - active: celecoxib 400mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate povidone sodium laurilsulfate tekprint green sb-4027 titanium dioxide - symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. for the management of acute pain and treatment of primary dysmenorrhoea in adults. the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. as the cardiovascular risks of the selective cox-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 100mg;   - capsule - 100 mg - active: pregabalin 100mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 150mg;   - capsule - 150 mg - active: pregabalin 150mg   excipient: colloidal silicon dioxide   gelatin   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide